Julie Jarecke Gebauer, President of Health, Wealth and Career at Willis Towers Watson PLC, filed a statement of changes in beneficial ownership on November 19, 2026, reporting a derivative securities transaction dated November 17, 2026.
Key Highlights
- Reporting person: Julie Jarecke Gebauer, identified as President - Health, Wealth and Career at Willis Towers Watson PLC (NASDAQ:WTW).
- Transaction: 77.0112 Restricted Share Units were acquired (transaction code A) on November 17, 2026 at a price of $0.
- Plan: The RSUs were credited under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees, net of units acquired pursuant to the participant's contribution under the Plan.
- Post-transaction holdings: Gebauer beneficially owned 5,734.095 derivative securities (RSUs) directly following the reported transaction.
- Underlying security: Each RSU corresponds on a 1:1 basis to one Ordinary Share with a nominal value of $0.000304635 per share.
- Settlement terms: Vested RSUs settle into Ordinary Shares on the first NASDAQ trading day of the month following the earlier of six months after separation from service or thirty days after the reporting person's death.
Gebauer's RSU Credit Under Willis Towers Watson's Excess Plan
According to the filing, the acquisition reflects RSUs credited to Gebauer's account under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees. The 77.0112 units represent the net amount after accounting for units acquired through the participant's own contribution under the Plan's accrual formula. The transaction price was reported as $0, consistent with an employer credit under a deferred compensation arrangement rather than an open-market purchase.
Willis Towers Watson PLC is a global advisory, broking, and solutions company. Gebauer serves as President of the Health, Wealth and Career segment, one of the company's primary operating divisions. The filing notes that the underlying securities are Ordinary Shares with a nominal value of $0.000304635 per share, and that RSUs convert to those shares on a 1:1 basis. The settlement of vested shares is deferred until the first business day of the month on which NASDAQ is open following the earlier of six months after the reporting person's separation from service or thirty days after death, as described in the filing's explanatory footnotes.
What Was Disclosed
The filing disclosed an acquisition of 77.0112 Restricted Share Units by Julie Jarecke Gebauer on November 17, 2026, under a Willis Towers Watson deferred compensation plan, bringing her total directly held RSU position to 5,734.095 units.





Please wait processing your request...